← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #650 OF 1,000 MOST-CITED

Lack of or inadequate procedures for distribution

FDA cited this observation 26 times across 25 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Devices26
BY FISCAL YEAR
FY20253
FY20233
FY20225
FY20213
FY20202
FY20194
FY20183
FY20173

How FDA worded it — real examples

Procedures for control and distribution of finished devices have not been established.

World Merchant Inc. · Broadlands, Virginia · Devices · 2025-04-16

Procedures for control and distribution of finished devices have not been established.

Philips Ultrasound, Inc · Reedsville, Pennsylvania · Devices · 2025-03-13

Procedures for control and distribution of finished devices have not been established.

Variamed, LLC · Chattanooga, Tennessee · Devices · 2024-12-18

Procedures for control and distribution of finished devices have not been adequately established.

QUICKSILVER SCIENTIFIC, INC · Louisville, Colorado · Devices · 2023-09-21

Procedures for control and distribution of finished devices have not been adequately established.

PHILIPS MEDICAL SYSTEMS NEDERLAND B.V. · Best · Devices · 2023-01-26

Procedures for control and distribution of finished devices have not been adequately established.

WHPM Inc. · Irwindale, California · Devices · 2022-11-18

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Pharmaceutical quality systemMedical devices

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →